Hostname: page-component-74656f9884-rngvg Total loading time: 0 Render date: 2026-11-06T11:12:25.292Z Has data issue: false hasContentIssue false

Expression of markers for germ cells and oocytes in cow dermal fibroblast treated with 5-azacytidine and cultured in differentiation medium containing BMP2, BMP4 or follicular fluid

Published online by Cambridge University Press:  03 July 2017

José Jackson do Nascimento Costa
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
Glaucinete Borges de Souza
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
Joyla Maria Pires Bernardo
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
Regislane Pinto Ribeiro
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
José Renato de Souza Passos
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
Francisco Taiã Gomes Bezerra
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
Márcia Viviane Alves Saraiva
Affiliation:
Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, CEP 62042–280, Sobral, CE, Brazil.
José Roberto Viana Silva*
Affiliation:
Biotechnology Nucleus of Sobral - NUBIS, Federal University of Ceara, Av. Comandante Maurocélio Rocha Ponte 100, CEP: 62.041–040, Sobral, CE, Brazil.
*
All correspondence to: J.R.V. Silva. Biotechnology Nucleus of Sobral – NUBIS, Federal University of Ceara, Av. Comandante Maurocélio Rocha Ponte 100, CEP: 62.041–040, Sobral, CE, Brazil. Tel:/Fax: +55 85 3611 8000. E-mail: jrvsilva@ufc.br
Rights & Permissions [Opens in a new window]

Summary

This study aims to investigate the effect 5-azacytidine (5-Aza) during induction of pluripotency in bovine fibroblasts and to evaluate the effects of BMP2, BMP4 or follicular fluid in the differentiation of reprogrammed fibroblasts in primordial germ cells and oocytes. It also analysis the mRNA levels for OCT4, NANOG, REX, SOX2, VASA, DAZL, cKIT, SCP3, ZPA and GDF9 after culturing 5-Aza treated fibroblasts in the different tested medium. Dermal fibroblasts were cultured and exposed to 0.5, 1.0 or 2.0 μM of 5-Aza for 18 h, 36 h or 72 h. Then, the cells were cultured in DMEM/F12 supplemented with 10 ng/ml BMP2, 10 ng/ml BMP4 or 5% follicular fluid. After culture, morphological characteristics, viability and gene expression were evaluated by qPCR. Treatment of skin fibroblasts with 2.0 μM 5-Aza for 72 h significantly increased expression of mRNAs for SOX2, OCT4, NANOG and REX. The culture in medium supplemented with BMP2, BMP4 or follicular fluid for 7 or 14 days induced formation of oocyte-like cells, as well as the expression of markers for germ cells and oocyte. In conclusion, treatment of bovine skin-derived fibroblasts with 2.0 μM 5-Aza for 72 h induces the expression of pluripotency factors. Culturing these cells in differentiation medium supplemented with BMP2, BMP4 or follicular fluid induces morphological changes and promotes expression of markers for germ cells, meiosis and oocyte.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2017 
Figure 0

Table 1 Primer pairs used in real-time PCR for quantification of markers of pluripotency, germ cells and oocytes genes expressed in cells cultured

Figure 1

Figure 1 Morphology of bovine fibroblasts before (A) and after exposure to 5-Aza (B). Fluorescence staining shows viable cells positive for calcein AM (C) and non-viable cells positive for ethidium homodimer-1 (D). Scale bar = 50 µm.

Figure 2

Figure 2 Levels of mRNA for SOX2 (A), NANOG (B), OCT4 (C) and REX (D) in fibroblasts cultured for 18 h in different concentrations of 5-Aza (0.5, 1.0 or 2.0 µM). (A,B)Different letters denote significant differences among treatments (P < 0.05).

Figure 3

Figure 3 Levels of mRNA for SOX2 (A), NANOG (B), OCT4 (C) and REX (D) in fibroblasts cultured for 36 h in different concentrations of 5-Aza (0.5, 1.0 or 2.0 µM). (A,B,C)Different letters denote significant differences among treatments (P < 0.05).

Figure 4

Figure 4 Levels of mRNA for SOX2 (A), NANOG (B), OCT4 (C) and REX (D) in fibroblasts cultured for 72 h in different concentrations of 5-Aza (0.5, 1.0 or 2.0 µM). (A,B,C)Different letters denote significant differences among treatments (P < 0.05).

Figure 5

Figure 5 Levels of mRNA for of pluripotency genes, (A) SOX2, (B) NANOG, (C) OCT4 and (D) REX, in fibroblasts cultured for 18 h, 36 h or 72 h with different concentrations of 5-Aza (0.5, 1.0 or 2.0 µM). (A,B,C)Different letters denote significant differences among treatments (P < 0.05).

Figure 6

Figure 6 Cells morphologically different from the starting cultures, with increased volume and round shape (arrow) after 7 days of culture. Scale bar = 50 µm.

Figure 7

Figure 7 Morphology of bovine fibroblasts exposed to 5-Aza and cultured in differentiation medium for 14 days. Fibroblast cultured for 14 days in medium supplemented with BMP2 (line 1), BMP4 (line 2) and follicular fluid (line 3), (A, D, G). Fluorescence staining shows viable cells positive for calcein AM (B, E, H) and non-viable cells positive for ethidium homodimer-1 (C, F, I). Scale bar = 100 µm. Arrows show oocyte-like structures formed after 14 days of culture.

Figure 8

Figure 8 Levels of mRNA for markers of germ cells: VASA (A, B), DAZL (C, D), and cKIT (E, F) in cells cultured for 7 days (A, C, E) or 14 days (B, D, F) in control medium alone or supplemented with BMP2, BMP4 and follicular fluid. (A,B)Different letters denote significant differences among treatments (P < 0.05).

Figure 9

Figure 9 Levels of mRNA for markers of oocytes [ZPA (A, B), GDF9 (C, D), SCP3 (E, F)] in cells cultured for 7 days (A, C, E) or 14 days (B, D, F) in control medium alone or supplemented with BMP2, BMP4 and follicular fluid. (A,B)Different letters denote significant differences among treatments (P < 0.05).

Figure 10

Figure 10 Levels of mRNA for markers of germ cells [VASA (A), DAZL (B) and cKIT (C)] and oocytes [ZPA (D), GDF9 (E) and SCP3 (F)] after culture cells for 0 (5-Aza), 7 or 14 days in control medium. (A,B,C)Different letters denote significant differences among treatments (P < 0.05).

Figure 11

Figure 11 Levels of mRNA for markers of germ cells [VASA (A), DAZL (B) and cKIT (C)] and oocytes [ZPA (D), GDF9 (E) and SCP3 (F)] after culture cells for 0 (5-Aza), 7 or 14 days in medium supplemented with 10 ng/ml of BMP2.

Figure 12

Figure 12 Levels of mRNA for markers of germ cells [VASA (A), DAZL (B) and cKIT (C)] and oocytes [ZPA (D), GDF9 (E) and SCP3 (F)] after culture cells for 0 (5-Aza), 7 or 14 days in medium supplemented with 10 ng/ml of BMP4. (A,B,C)Different letters denote significant differences among treatments (P < 0.05).

Figure 13

Figure 13 Levels of mRNA for markers of germ cells [VASA (A), DAZL (B) and ckit (C)] and oocytes [ZPA (D), GDF9 (E) and SCP3(F)] after culture cells for 0 (5-Aza), 7 or 14 days in medium supplemented with 5% follicular fluid. (A,B,C)Different letters denote significant differences among treatments (P < 0.05).